1. Home
  2. ADAG vs RFM Comparison

ADAG vs RFM Comparison

Compare ADAG & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • RFM
  • Stock Information
  • Founded
  • ADAG 2011
  • RFM 2020
  • Country
  • ADAG China
  • RFM United States
  • Employees
  • ADAG N/A
  • RFM N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • RFM Finance/Investors Services
  • Sector
  • ADAG Health Care
  • RFM Finance
  • Exchange
  • ADAG Nasdaq
  • RFM Nasdaq
  • Market Cap
  • ADAG 110.8M
  • RFM 88.7M
  • IPO Year
  • ADAG 2021
  • RFM N/A
  • Fundamental
  • Price
  • ADAG $1.79
  • RFM $14.30
  • Analyst Decision
  • ADAG Strong Buy
  • RFM
  • Analyst Count
  • ADAG 3
  • RFM 0
  • Target Price
  • ADAG $7.67
  • RFM N/A
  • AVG Volume (30 Days)
  • ADAG 78.0K
  • RFM 20.7K
  • Earning Date
  • ADAG 08-12-2025
  • RFM 01-01-0001
  • Dividend Yield
  • ADAG N/A
  • RFM 9.74%
  • EPS Growth
  • ADAG N/A
  • RFM N/A
  • EPS
  • ADAG N/A
  • RFM N/A
  • Revenue
  • ADAG $103,204.00
  • RFM N/A
  • Revenue This Year
  • ADAG $7,411.34
  • RFM N/A
  • Revenue Next Year
  • ADAG $28.29
  • RFM N/A
  • P/E Ratio
  • ADAG N/A
  • RFM N/A
  • Revenue Growth
  • ADAG N/A
  • RFM N/A
  • 52 Week Low
  • ADAG $1.33
  • RFM $12.89
  • 52 Week High
  • ADAG $3.16
  • RFM $16.41
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 41.71
  • RFM 49.07
  • Support Level
  • ADAG $1.75
  • RFM $14.26
  • Resistance Level
  • ADAG $1.95
  • RFM $14.43
  • Average True Range (ATR)
  • ADAG 0.12
  • RFM 0.11
  • MACD
  • ADAG -0.01
  • RFM -0.03
  • Stochastic Oscillator
  • ADAG 20.32
  • RFM 27.59

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: